Calcyphosine Antikörper (AA 1-109)
(1 reference)-
- Target Alle Calcyphosine (CAPS) Antikörper anzeigen
- Calcyphosine (CAPS)
-
Bindungsspezifität
- AA 1-109
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Calcyphosine Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, RNA Interference (RNAi)
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant CAPS.
- Sequenz
- MDAVDATMEK LRAQCLSRGA SGIQGLARFF RQLDRDGSRS LDADEFRQGL AKLGLVLDQA EAEGVCRKWD RNGSGTLDLE EFLRALRPPM SQAREAVIAA AFAKLDRSG
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- CAPS (NP_004049, 1 a.a. ~ 109 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 4C6
- Isotyp
- IgG1
-
anti-Calcyphosine (CAPS) (AA 1-189) antibody
CAPS Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS Reaktivität: Human WB, IHC (p) Wirt: Maus Polyclonal unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Calcyphosine (CAPS) (N-Term) antibodyCAPS Reaktivität: Human, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Calcyphosine (CAPS) (N-Term) antibodyCAPS Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Calcyphosine (CAPS) (N-Term) antibodyCAPS Reaktivität: Human, Pferd, Schwein, Kaninchen, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis." in: Journal of neuropathology and experimental neurology, Vol. 66, Issue 6, pp. 505-16, (2007) (PubMed).
-
: "Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis." in: Journal of neuropathology and experimental neurology, Vol. 66, Issue 6, pp. 505-16, (2007) (PubMed).
-
- Target
- Calcyphosine (CAPS)
- Andere Bezeichnung
- CAPS (CAPS Produkte)
- Synonyme
- CAPS1 antikoerper, Caps antikoerper, Caps1 antikoerper, Caps2 antikoerper, caps1 antikoerper, MGC84373 antikoerper, CAPS antikoerper, calcyphosine antikoerper, calcium dependent secretion activator antikoerper, calcyphosine S homeolog antikoerper, CAPS antikoerper, Cadps antikoerper, caps.S antikoerper, caps antikoerper, Caps antikoerper
- Hintergrund
-
Full Gene Name: calcyphosine
Synonyms: CAPS1,MGC126562 - Gen-ID
- 828
- NCBI Accession
- NM_004058
-
